Online citations, reference lists, and bibliographies.
← Back to Search

Nanoformulation Strategies For Improving Intestinal Permeability Of Drugs: A More Precise Look At Permeability Assessment Methods And Pharmacokinetic Properties Changes.

Delaram Babadi, S. Dadashzadeh, M. Osouli, Maryam Sadat Daryabari, A. Haeri
Published 2020 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The therapeutic efficacy of orally administered drugs is often restricted by their inherent limited oral bioavailability. Low water solubility, limited permeability through the intestinal barrier, instability in harsh environment of the gastrointestinal (GI) tract and being substrate of the efflux pumps and the cytochrome P450 (CYP) can impair oral drug bioavailability resulting in erratic and variable plasma drug profile. As more drugs with low membrane permeability are developed, new interest is growing to enhance their intestinal permeability and bioavailability. A wide variety of nanosystems have been developed to improve drug transport and absorption. Sufficient evidence exists to suggest that nanoparticles are able to increase the transepithelial transport of drug molecules. However, key questions remained unanswered. What types of nanoparticles are more efficient? What are preclinical (or clinical) achievements of each type of nanoformulation in terms of pharmacokinetic (PK) parameters? Addressing this issue in this paper, we have reviewed the current literature regarding permeability enhancement, permeability assessment methods and changes in PK parameters following administration of various nanoformulations. Although permeability enhancement by various nanoformulations holds great promise for oral drug delivery, many challenges still need to be addressed before development of more clinically successful nanoproducts.
This paper references
10.1016/j.ejpb.2018.06.022
Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet‐milling method
S. Huang (2018)
10.1208/s12248-016-9928-8
The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters—an Update
W. Zhang (2016)
10.1016/j.ijpharm.2011.10.048
Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Rishi Paliwal (2012)
10.1021/mp200287c
Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
Yonglong Zhang (2012)
10.2147/IJN.S121114
Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation
Rudra Pangeni (2016)
10.1016/j.dmpk.2017.11.003
Organ/body-on-a-chip based on microfluidic technology for drug discovery.
H. Kimura (2018)
10.1016/j.nano.2011.08.016
Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats.
Zhiwen Zhang (2012)
10.1080/03639045.2018.1438459
Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats
Joseph Shailender (2018)
10.1016/j.ijpharm.2014.02.009
Enhancing the intestinal absorption of low molecular weight chondroitin sulfate by conjugation with α-linolenic acid and the transport mechanism of the conjugates.
Yuliang Xiao (2014)
10.3109/10717544.2013.838077
Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations
H. Abdelkader (2014)
10.1080/10717544.2017.1391890
N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations
Cihui Tian (2017)
10.1021/acs.molpharmaceut.8b00809
Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
Yina Song (2019)
10.3109/10717544.2015.1039667
Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment
S. Katiyar (2016)
10.2147/IJN.S61181
Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization
Il-Woo Jung (2014)
10.1016/j.ejps.2011.04.005
Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
Tiecheng Zhang (2011)
10.1016/j.ijpharm.2013.07.079
Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
C. Feng (2013)
10.2147/IJN.S186899
Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability
Zaijin Teng (2019)
10.1016/j.drudis.2018.01.016
Pharmaceutical nanocrystals: production by wet milling and applications.
M. Malamatari (2018)
10.1016/j.ejpb.2012.10.003
Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.
Filipa Antunes (2013)
10.1021/la9034112
A promising drug controlled-release system based on diacetylene/phospholipid polymerized vesicles.
Caixin Guo (2009)
10.1038/srep43372
Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations
Helong Liu (2017)
10.1016/j.ejps.2012.04.002
Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
H. Han (2012)
10.3109/03639045.2013.850710
Design, optimization and evaluation of poly-ɛ-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir
P. R. Ravi (2015)
10.1016/j.colsurfb.2016.11.039
Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: Physicochemical characterization and in vivo evaluation.
O. Mustapha (2017)
10.2147/DDDT.S161940
Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement
A. Parikh (2018)
10.1016/J.COCIS.2010.10.003
Mixed micelles self-assembled from block copolymers for drug delivery
A. B. E. Attia (2011)
10.1002/adhm.201801123
Protein Corona Liposomes Achieve Efficient Oral Insulin Delivery by Overcoming Mucus and Epithelial Barriers.
Aohua Wang (2018)
10.3390/ijms17071171
Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs
W. Liu (2016)
10.1016/j.jconrel.2010.10.013
Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism.
F. Gao (2011)
10.2147/IJN.S164235
Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity
F. Siu (2018)
10.1080/08982104.2017.1343835
Niosomes for oral delivery of nateglinide: in situ–in vivo correlation
Amal A. Sultan (2018)
10.1016/S1875-5364(14)60012-1
Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Jin Shi-ying (2014)
10.1016/j.colsurfb.2019.02.039
Chylomicron mimicking nanocolloidal carriers of rosuvastatin calcium for lymphatic drug targeting and management of hyperlipidemia.
S. Beg (2019)
10.1016/j.colsurfb.2015.02.043
Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
M. Tariq (2015)
10.1016/j.ijbiomac.2014.03.006
Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose.
I. Baek (2014)
10.1080/21691401.2018.1546186
Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies
Mitali H Patel (2019)
10.2147/IJN.S139706
Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation
Ahmed N. Allam (2017)
10.1016/j.msec.2014.10.070
Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes.
Saeid Moghassemi (2015)
10.1016/j.ijpharm.2013.07.071
Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
S. Sadekar (2013)
10.1002/jps.22217
The developability classification system: application of biopharmaceutics concepts to formulation development.
J. Butler (2010)
10.1016/j.jconrel.2016.07.051
Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
Amrita Banerjee (2016)
10.1080/03639045.2018.1431656
Impact of various solid carriers and spray drying on pre/post compression properties of solid SNEDDS loaded with glimepiride: in vitro-ex vivo evaluation and cytotoxicity assessment
Sarvi Yadav Rajesh (2018)
10.2147/IJN.S51578
Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation
L. Zhao (2013)
10.1016/j.ijbiomac.2013.08.002
Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration.
D. Sakloetsakun (2013)
10.1016/j.ijpharm.2012.12.036
D-Alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensions.
Pengfei Yue (2013)
10.1080/14656566.2017.1414802
Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage
Kevin H Maniar (2018)
10.3390/pharmaceutics8030020
Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation
A. Nasr (2016)
10.1016/J.BBAMEM.2003.08.007
Association of hydrophobically-modified poly(ethylene glycol) with fusogenic liposomes.
D. Auguste (2003)
10.1177/039463201002300421
Bioavailability of Sandimmun® versus Sandimmun Neoral®: A Meta-Analysis of Published Studies
D. Colombo (2010)
10.1016/J.CLINTHERA.2006.09.014
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
J. Shah (2006)
10.1208/s12249-015-0388-8
Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System
V. Nekkanti (2015)
10.3109/08982104.2012.697067
Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery
S. K. R. Bobbala (2012)
10.1016/j.nano.2013.07.011
Biotinylated liposomes as potential carriers for the oral delivery of insulin.
X. Zhang (2014)
10.1039/c0nr00039f
Postsynthetic functionalization of mesoporous silica.
D. Brühwiler (2010)
10.1016/j.ejpb.2014.06.011
Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
T. Fan (2014)
10.1016/j.ejps.2018.04.016
Drug permeability profiling using cell-free permeation tools: Overview and applications.
Philippe Berben (2018)
10.1016/j.nano.2014.02.014
Intestinal absorption of insulin nanoparticles: contribution of M cells.
M. A. Lopes (2014)
10.1016/j.colsurfb.2017.03.006
Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability.
Vikram Kaithwas (2017)
10.1016/j.ejps.2008.06.009
Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.
B. Van Eerdenbrugh (2008)
10.1016/j.biomaterials.2014.05.053
Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
X. Wang (2014)
10.1016/j.ijpharm.2014.10.039
Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
P. Li (2014)
10.3390/molecules200814684
Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability
M. Krstić (2015)
10.1016/j.ijpharm.2012.04.025
A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
P. Quan (2012)
10.1080/21691401.2017.1324466
Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer
N. Ahmad (2018)
10.2174/1389450115666140804124808
Safety of Nanoparticles in Medicine.
Joy Wolfram (2015)
10.1016/j.ijpharm.2012.11.042
Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles.
R. Bhandari (2013)
10.1002/jps.24354
Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
P. Calleja (2015)
10.1016/j.ejps.2016.10.006
Prediction of drug intestinal absorption in human using the Ussing chamber system: A comparison of intestinal tissues from animals and humans
M. Miyake (2017)
10.1016/j.tox.2013.06.002
Intestinal transport of methylmercury and inorganic mercury in various models of Caco-2 and HT29-MTX cells.
M. Vázquez (2013)
10.2147/DDDT.S106356
Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D
Zhongcheng Ke (2016)
10.1016/j.jconrel.2015.07.033
Micro/nanofabricated platforms for oral drug delivery.
C. B. Fox (2015)
10.2174/1567201813666160115125756
Potential of Liposomes for Enhancement of Oral Drug Absorption.
Marjan Daeihamed (2017)
10.3109/03639045.2012.670641
Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge
Ashok Velpula (2013)
10.1016/j.jconrel.2014.06.042
Progress of drug-loaded polymeric micelles into clinical studies.
H. Cabral (2014)
10.2174/157016311796799062
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
R. Mueller (2011)
10.2217/nnm-2017-0007
Doxorubicin-loaded liposomes: enhancing the oral bioavailability by modulation of physicochemical characteristics.
Marjan Daeihamed (2017)
10.1185/03007995.2014.946123
Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study
A. Gibofsky (2014)
10.22037/IJPR.2010.897
Nanometric-Scaled Emulsions (Nanoemulsions)
R. Aboofazeli (2010)
10.2174/1389450115666141120114036
Drug nanocrystals: four basic prerequisites for formulation development and scale-up.
K. Srivalli (2015)
10.1016/j.ijpharm.2017.12.038
Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development.
Margherita Falavigna (2018)
10.1016/j.ejps.2017.11.004
Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability
Luíse L Chaves (2018)
10.1016/j.ejps.2016.05.010
Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
A. Karakucuk (2016)
10.1124/PR.112.005660
Strategies to Address Low Drug Solubility in Discovery and Development
H. Williams (2013)
10.3390/pharmaceutics10030158
Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin
Rudra Pangeni (2018)
10.1016/J.EJMECH.2006.01.013
Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model.
L-P Ruan (2006)
10.2147/IJN.S46900
Nanopharmaceuticals (part 1): products on the market
V. Weissig (2014)
10.1039/b717091b
An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models.
H. Kimura (2008)
10.1016/j.biomaterials.2018.10.012
Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs.
Yuling Mao (2019)
10.1016/j.colsurfb.2015.01.027
Fabrication of amorphous curcumin nanosuspensions using β-lactoglobulin to enhance solubility, stability, and bioavailability.
N. P. Aditya (2015)
10.1517/13543776.2013.761207
Dendrimer and cancer: a patent review (2006 – present)
X. Cai (2013)
10.1016/j.xphs.2015.10.002
Preparation and Physicochemical and Pharmacokinetic Characterization of Ginkgo Lactone Nanosuspensions for Antiplatelet Aggregation.
Tian-qi Rui (2016)
10.1021/mp300202c
Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).
S. Jain (2012)
10.1208/s12249-017-0790-5
Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement
Sonia Gera (2017)
10.3109/10717544.2015.1037969
In-vivo bioavailability and lymphatic uptake evaluation of lipid nanoparticulates of darunavir
M. Bhalekar (2016)
10.1016/j.ijpharm.2015.06.021
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles.
S. Barbieri (2015)
10.3109/10611869808997871
Drug delivery systems for cyclosporine: achievements and complications.
B. A. Klyashchitsky (1998)
10.1016/j.ijpharm.2015.07.048
Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: Systematic development, in vitro, ex vivo and in vivo evaluation.
S. Beg (2015)
10.1166/JBN.2015.2110
Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities.
J. Wu (2015)
10.1016/j.ejps.2014.04.014
Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
G. Joshi (2014)
10.1080/10717544.2016.1196768
Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin
S. Ullah (2016)
10.3109/10717544.2015.1008705
In vitro and in vivo study of Baicalin-loaded mixed micelles for oral delivery
Haiqun Zhang (2016)
10.1016/j.ijpharm.2014.06.031
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
Ketan Patel (2014)
10.1016/j.colsurfb.2013.09.010
Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration.
J. Dou (2014)
10.1016/j.ejpb.2013.12.015
Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism.
P. R. Ravi (2014)
10.2174/2211738503666150709173905
Recent Advances in Liposomal Drug Delivery: A Review
Vijaykumar Nekkanti and Sandeep Kalepu (2015)
10.2147/IJN.S120887
Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate
Hongzhi Qiao (2017)
10.1016/j.jconrel.2016.10.002
The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.
Lungile Nomcebo Thwala (2016)
10.1016/j.ejpb.2015.04.013
Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems.
T. Karamanidou (2015)
10.1002/jps.23858
Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
Thanh Huyen Tran (2014)
10.1016/j.addr.2016.04.014
Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier.
A. Beloqui (2016)
10.1007/s11095-016-1958-5
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo (2016)
10.1021/mp500833m
Improved oral absorption of doxorubicin by amphiphilic copolymer of lysine-linked ditocopherol polyethylene glycol 2000 succinate: in vitro characterization and in vivo evaluation.
J. Wang (2015)
10.2217/nnm.11.166
Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
J. Rosenholm (2012)
10.1016/j.jep.2012.05.047
Pharmacokinetics, tissue distribution and metabolism of senkyunolide I, a major bioactive component in Ligusticum chuanxiong Hort. (Umbelliferae).
Chun-yong He (2012)
10.1016/j.addr.2016.07.007
Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues.
P. Lundquist (2016)
10.1111/jphp.12103
Enhanced intestinal absorption activity and hepatoprotective effect of herpetrione via preparation of nanosuspensions using pH‐dependent dissolving‐precipitating/homogenization process
Baode Shen (2013)
10.2147/IJN.S19259
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt
Peipei Guan (2011)
10.1080/03639045.2016.1239732
A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin
M. Shukla (2017)
10.1021/mp400175n
Mediation of in vitro cytochrome p450 activity by common pharmaceutical excipients.
P. Martin (2013)
10.1016/J.IJPHARM.2004.08.001
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
Y. Wu (2004)
10.1016/j.ijpharm.2015.10.078
Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin.
P. Zhang (2015)
Clinical studies with oral lipid based formulations of poorly soluble compounds
D. Fatouros (2007)
10.1021/mp300441c
Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability.
S. H. Moghadam (2013)
10.1080/21691401.2016.1246451
Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime
M. Imran (2017)
10.3109/17435390.2014.948091
Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices
D. E. Lefebvre (2015)
10.1021/mp400311j
Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
A. Jain (2013)
10.1016/j.jconrel.2017.06.003
Nanosizing techniques for improving bioavailability of drugs
Raida Al-Kassas (2017)
10.1080/10717544.2016.1245370
Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles
J. Hou (2017)
10.1016/j.jconrel.2010.11.022
G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
Deborah S. Goldberg (2011)
10.3109/10717544.2016.1153744
Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus
Q. Yu (2016)
10.1016/j.ijpharm.2013.10.003
Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies.
F. Araújo (2013)
10.1615/CRITREVTHERDRUGCARRIERSYST.2015011865
Oral Absorption Promoters: Opportunities, Issues, and Challenges.
Chetan Yewale (2015)
10.1016/j.colsurfb.2016.02.065
Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel.
Bingjun Sun (2016)
10.2217/nnm.09.110
Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.
E. Roger (2010)
10.1007/s11095-013-1063-y
Improved Oral Bioavailability of BCS Class 2 Compounds by Self Nano-Emulsifying Drug Delivery Systems (SNEDDS): The Underlying Mechanisms for Amiodarone and Talinolol
Anna Elgart (2013)
10.1002/jps.24015
Preparation and solidification of redispersible nanosuspensions.
X. Zhang (2014)
10.22037/IJPR.2019.2345
An Investigation into the Role of P-Glycoprotein in the Intestinal Absorption of Repaglinide: Assessed by Everted Gut Sac and Caco-2 Cell Line
Morteza Yaghoobian (2019)
10.1016/j.ijpharm.2010.07.044
Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
R. Shegokar (2010)
10.1166/JBN.2011.1294
Chitosan coated furosemide liposomes for improved bioavailability.
I. Vural (2011)
10.1021/mp5005838
Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions.
J. Zhou (2015)
10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
10.1166/JBN.2013.1613
Self-nanoemulsifying lipid carrier system for enhancement of oral bioavailability of etoposide by P-glycoprotein modulation: in vitro cell line and in vivo pharmacokinetic investigation.
N. Akhtar (2013)
10.2217/nnm.13.8
Therapeutic nanoparticles in clinics and under clinical evaluation.
Catherine A. Schütz (2013)
10.1080/10717544.2018.1425773
Modified mixed nanomicelles with collagen peptides enhanced oral absorption of Cucurbitacin B: preparation and evaluation
L. Tang (2018)
10.1016/j.plipres.2017.07.001
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
M. C. Teixeira (2017)
10.1517/17425247.2013.799136
Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis
K. Hosny (2013)
10.1021/bm401580k
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
10.1016/j.actbio.2017.10.025
Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Y. Wang (2018)
10.3109/10717544.2014.923956
Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations
Sharmeen Fatma (2016)
10.1016/j.addr.2012.10.010
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.
M. Chen (2013)
10.1016/j.nano.2015.02.011
G5 PAMAM dendrimer versus liposome: a comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin.
R. Qi (2015)
10.3109/08982104.2011.621127
N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin
Huanlei Chen (2012)
10.1016/j.addr.2012.11.005
Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
L. Mei (2013)
10.1016/j.ijpharm.2014.12.068
Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
Xiaotong Zhou (2015)
10.1208/s12249-014-0177-9
Nanomedicine Scale-up Technologies: Feasibilities and Challenges
R. Paliwal (2014)
10.1016/j.ejps.2016.12.015
Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan
Nikhil Biswas (2017)
10.1016/j.ejps.2011.12.007
In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives.
S. T. Buckley (2012)
10.1016/j.ejpb.2014.12.026
TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
Yating Shao (2015)
10.1016/j.ijpharm.2015.07.075
Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
E. B. Basalious (2015)
10.1080/21691401.2017.1408123
Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies
A. Haeri (2018)
10.1016/j.phymed.2017.12.021
Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
M. Singh (2018)
10.1080/03639045.2019.1593434
Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia
Mitali H Patel (2019)
10.2147/IJN.S20903
Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer
Qi Shen (2011)
10.1016/j.colsurfb.2015.05.056
The mechanism of self-assembled mixed micelles in improving curcumin oral absorption: In vitro and in vivo.
J. Wang (2015)
10.1016/j.ijpharm.2017.06.052
Polymeric nanoparticles: Promising platform for drug delivery.
K. El-Say (2017)
10.1016/j.ddtec.2011.12.001
Overcoming poor oral bioavailability using nanoparticle formulations - opportunities and limitations.
Preshita P Desai (2012)
10.1111/jphp.12448
The studies of N‐Octyl‐N‐Arginine‐Chitosan coated liposome as an oral delivery system of Cyclosporine A
J. Deng (2015)
10.1111/jphp.12217
A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation
P. R. Ravi (2014)
10.1016/j.ijpharm.2016.10.064
In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles.
A. Garg (2017)
10.1016/j.ijpharm.2013.03.033
Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
X. Liu (2013)
10.1016/j.ijpharm.2013.08.037
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Archana Bagre (2013)
10.1016/j.ijpharm.2016.11.056
Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
Y. Liu (2017)
10.2217/nnm.15.36
Oral insulin delivery using deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles.
K. Chaturvedi (2015)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1185/03007995.2015.1112772
Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study
R. D. Altman (2015)
10.1177/2160763X12447304
A Single‐Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects
C. Shadle (2012)
10.3109/10717544.2015.1028600
Lymphatic transport of orally administered probucol-loaded mPEG-DSPE micelles
Limei Han (2016)
10.1016/j.ejps.2014.06.008
Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug.
X. Zhang (2014)
10.1248/BPB1978.5.120
Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets.
N. Aoyagi (1982)
10.1016/j.biomaterials.2015.03.054
Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies.
C. Pereira (2015)
10.1016/j.ejps.2019.02.021
Enhanced dissolution/caco‐2 permeability, pharmacokinetic and pharmacodynamic performance of re‐dispersible eprosartan mesylate nanopowder
Prachi B. Shekhawat (2019)
10.1007/s11095-006-9122-2
Transport of Poly(Amidoamine) Dendrimers across Caco-2 Cell Monolayers: Influence of Size, Charge and Fluorescent Labeling
Kelly M. Kitchens (2006)
10.1016/j.ijpharm.2016.03.065
Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
V. Nekkanti (2016)
10.1007/s13346-016-0297-8
Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability
S. Jain (2016)
10.1016/j.apsb.2014.08.001
Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide–maltodextrin complex
R. K. Sahoo (2014)
10.2147/IJN.S56648
Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake
H. Cho (2014)
10.1016/j.ejps.2015.03.019
New biomimetic barrier Permeapad™ for efficient investigation of passive permeability of drugs.
M. D. di Cagno (2015)
10.3109/03639045.2012.717945
Enhanced oral bioavailability of isradipine via proniosomal systems
P. R. Veerareddy (2013)
10.3390/molecules22091401
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Livia Palmerston Mendes (2017)
10.3109/03639045.2012.746362
Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation
G. V. Patel (2014)
10.1016/J.CLINTHERA.2004.09.015
A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
Pol-Henri Guivarc'h (2004)
10.2147/IJN.S6308
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension
B. Deschamps (2009)
10.1016/j.ejpb.2017.04.013
Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake
J. Baek (2017)
10.1080/17425247.2018.1517748
Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives
Vu Thanh Cong (2018)
10.1021/acs.molpharmaceut.6b01165
Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monoculture.
Isabel Lozoya‐Agullo (2017)
10.1021/acs.molpharmaceut.5b00010
Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus.
Dong Zhang (2015)
10.3109/03639045.2014.947510
Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system
Y. Ma (2015)
10.1007/s10544-017-0179-y
Microfluidic gut-on-a-chip with three-dimensional villi structure
Kyu-Young Shim (2017)
10.1016/j.ejps.2016.01.012
Polymeric nanoparticles for oral delivery of 5-fluorouracil: Formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study.
Ana Cristina de Mattos (2016)
10.3109/03639045.2012.694588
Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel
J. Wu (2013)
10.1016/j.jcis.2017.11.065
Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
Ying Wang (2018)
10.1002/ART.1780310314
Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats.
E. C. Soehngen (1988)
10.3109/03639045.2012.683440
Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate
A. Bajaj (2013)
10.2217/nnm-2018-0289
Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations.
R. S. Managuli (2019)
10.1208/s12249-016-0632-x
Self-Nanoemulsifying Drug Delivery System of Coenzyme (Q10) with Improved Dissolution, Bioavailability, and Protective Efficiency on Liver Fibrosis
Abeer H. B. Khattab (2016)
10.3109/10717544.2015.1039666
Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats
M. J. Ansari (2016)
10.1016/j.ejpb.2019.06.025
Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: a review of preclinical research.
H. Al-Lawati (2019)
10.1016/j.addr.2013.01.002
Targeted nanoparticles with novel non-peptidic ligands for oral delivery.
A. des Rieux (2013)
10.1016/j.ejpb.2011.01.007
State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.
R. Mueller (2011)
10.1016/j.carbpol.2016.10.063
Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery.
Sonia Alavi (2017)
10.1080/10717544.2017.1344335
A novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for improved stability and oral bioavailability of an oily drug, 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol
Kyeong Soo Kim (2017)
10.1016/j.carbpol.2018.11.099
Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel.
Guowei Qu (2019)
10.1016/j.addr.2010.12.007
Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
E. Merisko-Liversidge (2011)
10.1016/j.ijpharm.2013.01.065
Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption.
Q. Fu (2013)
10.1208/s12249-018-1118-9
Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol
Samaneh Ghassemi (2018)
10.3390/pharmaceutics11020097
Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations
A. Khan (2019)
10.2147/IJN.S34991
Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine
Yan Chen (2012)
10.1016/j.ejpb.2013.08.003
Supersaturated polymeric micelles for oral cyclosporine A delivery.
H. Yu (2013)
10.1016/j.jconrel.2010.01.036
Endocytosis of nanomedicines.
G. Sahay (2010)
10.1016/j.ejpb.2011.10.010
Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge.
Karthik Yadav Janga (2012)
10.1016/j.nano.2016.03.003
Triple antioxidant SNEDDS formulation with enhanced oral bioavailability: Implication of chemoprevention of breast cancer.
S. Tripathi (2016)
10.2217/nnm.12.141
Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.
Chunhui Chen (2013)
10.3390/pathogens2010055
Goblet Cells and Mucins: Role in Innate Defense in Enteric Infections
Janice J. Kim (2013)
10.1517/17425247.2012.694865
Microemulsions for oral administration and their therapeutic applications
S. Gibaud (2012)
10.1021/mp100289v
Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption.
H. Yuan (2011)
10.1080/21691401.2017.1362414
Mesoporous silica nanorods for improved oral drug absorption
N. Zheng (2018)
10.2217/nnm.10.126
Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances.
A. Date (2010)
10.3109/03639045.2015.1104344
Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro–in vivo evaluations
K. Sawant (2016)
10.3109/10717544.2016.1167270
Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers
J. Hou (2016)
10.1016/j.colsurfb.2018.11.029
Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.
Ruoning Wang (2019)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar